Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2023
Impact of Minimal Residual Disease on Progression-Free Survival Outcomes After Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW StudyTalha Munir, Carol Moreno, Carolyn Owen, et al.
Future Oncology (London, England)|December 13, 2023
Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatmentJennifer R Brown, Barbara Eichhorst, Peter Hillmen, et al.
The New England Journal of Medicine|December 13, 2022
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic LeukemiaJennifer R Brown, Barbara Eichhorst, Peter Hillmen, et al.
The Journal of Clinical Investigation|October 22, 2024
FoxO1/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemiaLaura Ondrisova, Vaclav Seda, Krystof Hlavac, et al.
Physical Review Letters|December 31, 2005
First results of the search for neutrinoless double-beta decay with the NEMO 3 detectorR Arnold, C Augier, J Baker, et al.
Blood Advances|October 24, 2025
Central Nervous System Involvement in CLL: An International Retrospective Study by ERIC, the European Research Initiative on CLLThomas Chatzikonstantinou, Mariia Mikhaleva, Christian Brieghel, et al.
Physical Review Letters|September 10, 2011
Measurement of the ββ decay half-life of 130Te with the NEMO-3 detectorR Arnold, C Augier, J Baker, et al.
Acta Crystallographica. Section D, Structural Biology|June 1, 2023
The CCP4 suite: integrative software for macromolecular crystallographyJon Agirre, Mihaela Atanasova, Haroldas Bagdonas, et al.
Pageof 14